Search results

  1. V.R.T.

    STIMULATE-ICP: [...] Phase III, open label, adaptive platform randomised drug trial in [LC]: [Protocol], 2023, Forshaw et al

    Open label? Open label? What is the point of an open label phase 3 trial? Surely that's just a very large pilot? And this study was supposed to report in 2023. What exactly is the hold up? I was hoping we'd at least get good data on famotidine/loratadine in an RCT. Oh well. Maybe the...
  2. V.R.T.

    A patient perspective on enduring symptoms – the unmet need, 2025, Cheston

    This article is good, although I think if it's intended for doctors the anecdote about the teeth is the exact sort of thing more callous doctors who believe we're all hypochondriacs tend to laugh at. It was good that the conclusion highlighted DecodeME. And the section on disengagement from...
  3. V.R.T.

    STIMULATE-ICP: [...] Phase III, open label, adaptive platform randomised drug trial in [LC]: [Protocol], 2023, Forshaw et al

    It is insane to me this trial has taken what - four years? Without adding other drugs. These are very basic drugs, and if they help pwLC we should have had that info years ago and moved on. There should be a Stimulate ICP anti cd38 or even JAK inhibitor trial in the works. There should have been...
  4. V.R.T.

    Large-scale investigation confirms TRPM3 ion channel dysfunction in ME/CFS, 2025, Marshall-Gradisnik et al

    Does anyone knowledgable have any opinions on whether this paper in fact strengthens the groups previous findings or whether it repeats the problems with the previous papers at a larger scale?
  5. V.R.T.

    Large-scale investigation confirms TRPM3 ion channel dysfunction in ME/CFS, 2025, Marshall-Gradisnik et al

    Would this count as a 'large scale investigation' as far as patch clamping goes then?
  6. V.R.T.

    The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy, Korst et al. 2025

    https://immunitybio.com/immunitybio-announces-phase-2-study-of-anktiva-in-patients-with-long-covid/ Seems like theyre thinking along viral persistance lines Or are you trying to boost your NK count for Daratumumab?
  7. V.R.T.

    Long COVID involves activation of proinflammatory and immune exhaustion pathways, 2025, Aid et al.

    That's interesting and a little dismaying as I had been entertaining a bit of hope that these findings might be relevant for ME/CFS too. Especially in light of the JAK-STAT trials. On a related note, I remember you saying that if something you were speculating about had merit then hopefully...
  8. V.R.T.

    SequenceME genetic study - from Oxford Nanopore Technologies, the University of Edinburgh and Action for ME

    How long do you think we are going to have to wait to find out if SequenceME got funded? Last I heard they were seeking funding in the states and maybe we'd know by end of November whether that was successful.
  9. V.R.T.

    Long COVID involves activation of proinflammatory and immune exhaustion pathways, 2025, Aid et al.

    Do you know of any similar studies that have looked at JAK STAT pathways and Il-6 in non LC ME and come up negative?
  10. V.R.T.

    Reddit - Interesting posts on Reddit, including what some doctors say about ME/CFS

    No need to say anything, but thanks. I shared initially to show that there are myriad reasons why people might keep going back to the doctor, or not fully understand what is going on with them. Our story is particularly sad in that it happened to both of us but other than that I don't think it's...
  11. V.R.T.

    Reddit - Interesting posts on Reddit, including what some doctors say about ME/CFS

    After our bout of strep, both my partner and I developed chronic tonsillitis. Hers was much worse, with big white patches on her tonsils and within a year and a half they were in such a hideous state that doctors refused to perform an operation where she would need to be intubated until they...
  12. V.R.T.

    United Kingdom: ME Association governance issues

    I suppose we have to push for the right people to get involved. This is such an appalling situation.
  13. V.R.T.

    Is a lymph node biopsy study in ME/CFS feasible?

    Those pesky lymph nodes have a lot to answer for!
  14. V.R.T.

    United Kingdom: ME Association governance issues

    I think this is a very important point. It shouldn't be up to us to word things perfectly so NHS administrators and BACME can't twist our words and give us GET 3.0: Now With More Patronising Bullshit. Patients want to be treated by doctors who understand the condition and given adequate care...
  15. V.R.T.

    NYC-based ME/CFS doctors recs? (excluding Susan Levine)

    Any word on how people respond?
  16. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    That gives some creedence to the idea that NK cell separation in responders/non responders is related to drug action not disease mechnism.
Back
Top Bottom